相关实验视频

Updated: Sep 19, 2025

Generation of a Gene-disrupted Streptococcus mutans Strain Without Gene Cloning

Generation of a Gene-disrupted Streptococcus mutans Strain Without Gene Cloning

Published on: October 23, 2017

获得的CRISPR间隔器和拉姆诺斯-葡萄糖多糖体缺陷使人对Streptococcus mutans菌APCM01产生抵抗力

Lucas A Wall¹, Daniel Wall¹

¹Department of Molecular Biology, University of Wyoming, Laramie, WY 82071, USA.

Microbiology (Reading, England)

|June 19, 2025

概括

菌体 (菌体) 提供针对性治疗Streptococcus mutans,牙损伤的原因. 菌体对S. mutans的耐药性是通过CRISPR间隔器或rhamnose-glucose polysaccharide (rgp) 突变形成的,这些突变会损害菌体结合,但会带来健康成本.

科学领域:

微生物学微生物学
细菌治疗疗法是一种细菌治疗.
牙损研究牙损研究

背景情况:

突变性链球菌 (Streptococcus mutans) 是全球牙损伤的主要致病因.
菌体 (菌体) 由于其特异性,对向的S. mutans疗法具有前景.
了解菌体耐药机制对于开发有效的菌体治疗非常重要.

研究的目的:

为了研究菌素耐药性发展的机制在Streptococcus mutans.
描述菌素耐药性对细菌健康和病原性的影响.
评估菌APCM01对不同S. mutans血清型的感染潜力.

主要方法:

隔离和全基因组测序15个自发的菌素耐药S. mutans突变体.
识别新型聚类正规间隔的短平行体重复 (CRISPR) 间隔器.
分析拉姆诺斯-葡萄糖多糖 (RGP) 生物合成基因的突变及其对菌体吸附和细菌适应性的影响.

主要成果:

十种耐药突变获得了针对菌体的新型CRISPR间隔器;发现了18种新的间隔器.
八个突变者在rgp基因中发生了突变;rgp突变者表现出菌体吸附的缺陷,表明rhamnose-glucose多糖化物是菌体受体.
在rgpF和rgpX的突变导致细胞分裂缺陷和受损的生物膜形成,赋予耐药性与健身成本.

结论:

菌体对S. mutans的耐药性主要来自CRISPR间隔器的获取或rgp基因的突变.
Rgp突变赋予了菌体耐药性,但却带来了显著的适应性成本,可能限制了病原性.
APCM01菌体可以感染e型和c型血清菌株,这表明其具有广泛的治疗潜力.

关键词:

突变型链球菌 (Streptococcus mutans) 是一种突变型链球菌细菌菌体是一种菌体.聚类有规律间隔的短平行体重复 (CRISPR) -Cas 牙腐烂是指牙的腐烂.电阻的阻力可以拉姆诺斯-葡萄糖多糖化物.

更多相关视频

Purification of a High Molecular Mass Protein in Streptococcus mutans

Purification of a High Molecular Mass Protein in Streptococcus mutans

Published on: September 14, 2019

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

Published on: September 18, 2018

相关概念视频

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

The Antiviral System of Bacteria and Archaea: CRISPR

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...